ABO Group and Rh Type – ABO type and Rh are needed to identify candidates for Rh immune globulin and to assess the risk of hemolytic disease of the newborn.

Test results include: Blood Type (ABO and RH)

If you do not wish to have the entire panel done, you can get results for any specific allergen from the results list below. (Each individual test is $21)

Allergy to the following allergens:

• Almond (f20))
• Cashew Nut (f202))
• Codfish (f3))
• Cow’s Milk (f2))
• Egg White (f1))
• Hazelnut (f17))
• Peanut (f13))
• Salmon (f41))
• Scallop (f338))
• Sesame Seed (f10))
• Shrimp (f24))
• Soybean (f14))
• Tuna (f40))
• Walnut (f256))
• Wheat (f4))

If you do not wish to have the entire panel done, you can get results for any specific allergen from the results list below. (Each individual test is $21)

Allergy to the following allergens:

• Alternaria alternata (m6))
• Aspergillus fumigatus (m3))
• Cladosporium herbarum (m2))
• Mucor racemosus (m4))
• Penicillium notatum (m1))
• Stemphylium botryosum (m10))

If you do not wish to have the entire panel done, you can get results for any specific allergen from the results list below. (Each individual test is $21)

Allergy to the following allergens:

• Alternaria alternata
  
• Aspergillus fumigatus
  
• Bermuda grass (Cynodon dactylon)
• Cat dander
  
• Cladosporium herbarum (Hormodendrum)
• Cockroach
• Common Ragweed (short)
• Cottonwood (Populous deltoides)
• Dermatophagoides farinae
• Dermatophagoides pteronyssinus
• Dog dander
• Elm
• Maple (box elder)
• Maple leaf sycamore, London Plane
• Mountain cedar (Juniperus sabinoides)
• Mouse Urine Proteins
• Mulberry
  
• Oak
• Pecan/Hickory (Carya soecue, pecan)
• Penicillium notatum
• Rough marsh elder
• Rough pigweed (Amaranthus retroflexus)
• Russian thistle (Saltwort, Salsola kali)
• Timothy grass (Phleum pratense)
• Walnut (Juglans californica)
  
• White ash (Fraxinus americana)

Test results include:

Allergy to the following Seafood:

• Codfish
• Crab
• Lobster
• Salmon
• Shrimp
• Tuna

Test results include:

Allergy to the following Nuts:

• Almond
  
• Brazil Nut
  
• Cashew Nut
  
• Hazelnut
  
• Macadamia Nut
  
• Peanut
  
• Pecan Nut
  
• Pistachio
  
• Walnut
  

Alpha-Fetoprotein, Tumor Marker – Elevation of serum AFP above values found in healthy individuals occurs in several malignant diseases, most notably nonseminomatous testicular cancer and primary hepatocellular carcinoma. AFP is not recommended as a screening procedure to detect cancer in the general population.

Test results include: Alpha-Fetoprotein

CA 125 – The CA 125 level can provide prognostic information in the follow-up management of patients with ovarian carcinoma. The assay should be used as an adjunctive test in the management of ovarian cancer patients. CA 125 is not recommended as a cancer screening procedure to detect cancer in the general population.

Test results include: CA 125

CA 15-3 – CA 15-3 may be useful for monitoring patients with metastatic breast cancer and certain ovarian cancers. The CA 15-3 values from sequential samples have a high correlation with the clinical course in most patients with metastatic breast cancer.

Test results include: CA 15-3

CA 19-9 – A large percentage of patients with gastrointestinal tumors (such as pancreatic, liver, gastric, colorectal tumors) and some other malignancies have been shown to have elevated serum CA 19-9 levels. Serum CA 19-9 levels may be useful for monitoring disease activity or predicting relapse following treatment. CA 19-9 should not be used as a screening test.

Test results include: CA 19-9

CA 27.29 – CA 27.29 may be useful for monitoring patients for metastatic breast cancer.

Test results include: CA 27.29

CEA – Increased serum CEA levels have been detected in persons with primary colorectal cancer and in patients with other malignancies involving the gastrointestinal tract, breast, lung, ovarian, prostatic, liver and pancreatic cancers. Elevated serum CEA levels have also been detected in patients with nonmalignant disease, especially patients who are older or who are smokers. CEA levels are not useful in screening the general population for undetected cancers. However, CEA levels provide important information about patient prognosis, recurrence of tumors after surgical removal, and effectiveness of therapy.

Test results include: CEA

CMP – The Complete Metabolic Panel test provides an important summary of heart health, as well as liver and kidney function.

Test results include: Albumin, Albumin/Globulin Ratio (calculated), Alkaline Phosphatase, ALT, AST, BUN/Creatinine Ratio (calculated), Calcium, Carbon Dioxide, Chloride, Creatinine with GFR Estimated, Globulin (calculated), Glucose, Potassium, Sodium, Total Bilirubin, Total Protein, Urea Nitrogen

Complete Blood Count w/Differential – CBC (includes Differential and Platelets) – A complete blood count is used as a screening test for various disease states to include: anemia, leukemia and inflammatory processes. (Fasting recommended)

Test results include: WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, RDW, Platelet Count, MPV with Differential

Cortisol, Total – Cortisol is increased in Cushing’s Disease and decreased in Addison’s Disease (adrenal insufficiency).

Test results include: Cortisol, Total

High Sensitivity C-Reactive Protein (hs-CRP) – Useful in predicting risk for cardiovascular disease.

Test results include: CRP

C-Reactive Protein (CRP) – Increased CRP levels are found in inflammatory conditions including: bacterial infection, rheumatic fever, active arthritis, myocardial infarction, malignancies and in the post-operative state. This test cannot detect the relatively small elevations of CRP that are associated with increased cardiovascular risk.

Test results include: CRP

DHEA-S is the sulfated form of DHEA and is the major androgen produced by the adrenal glands. This test is used in the differential diagnosis of hirsute or virilized female patients and for the diagnosis of isolated premature adrenarche and adrenal tumors. About 10% of hirsute women with Polycystic Ovarian Syndrome (PCOS) have elevated DHEA-S but normal levels of other androgens.

Test results include: DHEA-S Immunoassay

Diabetic Screen – Hemoglobin A1c – To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.

Test results include: Hemoglobin A1c

Sed Rate by Modified Westergren (ESR) – Useful in differentiating inflammatory and neoplastic diseases and as an index of disease severity. CRP is also useful in monitoring inflammatory disease states.

Test results include: Sed Rate by Modified Westergren

Epstein-Barr Virus Antibody Panel – Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. VCA-IgM is typically detectable at clinical presentation, then declines to undetectable levels within a month in young children and within 3 months in other individuals. VCA-IgG is typically detectable at clinical presentation, and persists for life. EBNA IgG typically appears during convalescence (3-4 months after clinical presentation) and remains detectable for life.

Test results include: Epstein-Barr Virus VCA Antibody (IgM), Epstein-Barr Virus VCA Antibody (IgG), Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG)

Epstein-Barr Virus Early Antigen D Antibody (IgG) – Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. IgG recognizing Early Antigen D typically appears within a month after clinical presentation and is transient, lasting only 3-4 months. Persistently elevated levels suggest reactivation or persistence of EBV infection.

Test results include: Epstein-Barr Virus Early Antigen D Antibody (IgG)

Estradiol – Measuring the circulating levels of estradiol is important for assessing the ovarian function and monitoring follicular development for assisted reproduction protocols. Estradiol plays an essential role throughout the human menstrual cycle. Elevated estradiol levels in females may also result from primary or secondary ovarian hyperfunction. Very high estradiol levels are found during the induction of ovulation for assisted reproduction therapy or in pregnancy. Decreased estradiol levels in females may result from either lack of ovarian synthesis (primary ovarian hypofunction and menopause) or a lesion in the hypothalamus-pituitary axis (secondary ovarian hypofunction). Elevated estradiol levels in males may be due to increased aromatization of androgens, resulting in gynecomastia.

Test results include: Estradiol

Estrogen, Total, Serum – Estrogens are secreted by the gonads, adrenal glands, and placenta. Total estrogens provide an overall picture of estrogen status for men and women

Test results include: Estrogen Total

Estrone – Estrone is primarily derived from metabolism of androstenedione in peripheral tissues, especially adipose tissues. Individuals with obesity have increased conversion of androstenedione to Estrone leading to higher concentrations. In addition, an increase in the ratio of Estrone to Estradiol may be useful in assessing menopause in women.

Test results include: Estrone

Ferritin – Useful in the diagnosis of hypochromic, microcytic anemias. Decreased in iron deficiency anemia and increased in iron overload.

Test results include: Ferritin

Folate, Serum – Folic acid deficiency is common in pregnant women, alcoholics, in patients whose diets do not include raw fruits and vegetables, and in people with structural damage to the small intestine. The most reliable and direct method of diagnosing folate deficiency is the determination of folate levels in both erythrocytes and serum. Low folic acid levels, however, can also be the result of a primary vitamin B₁₂ deficiency that decreases the ability of cells to take up folic acid.

Test Results include: Folate (Folic Acid)

FSH and LH – FSH and LH are secreted by the anterior pituitary in response to gonadotropin-releasing hormone (GNRH) secreted by the hypothalamus. In both males and females, FSH and LH secretion is regulated by a balance of positive and negative feedback mechanisms involving the hypothalamic-pituitary axis, the reproductive organs, and the pituitary and sex steroid hormones. FSH and LH play a critical role in maintaining the normal function of the male and female reproductive systems. Abnormal FSH levels with corresponding increased or decreased levels of LH, estrogens, progesterone, and testosterone are associated with a number of pathological conditions. Increased FSH levels are associated with menopause and primary ovarian hypofunction in females and primary hypogonadism in males. Decreased levels of FSH are associated with primary ovarian hyper-function in females and primary hypergonadism in males. Normal or decreased levels of FSH are associated with polycystic ovary disease in females. In males, LH is also called interstitial cell-stimulating hormone (ICSH). Abnormal LH levels with corresponding increased or decreased levels of FSH, estrogens, progesterone, and testosterone are associated with a number of pathological conditions. Increased LH levels are associated with menopause, primary ovarian hypofunction, and polycystic ovary disease in females and primary hypo-gonadism in males. Decreased LH levels are associated with primary ovarian hyperfunction in females and primary hyper-gonadism in males.

Test results include: FSH, LH

Glucose-6-Phosphate Dehydrogenase – G-6-PD is the most common enzyme deficiency in the world. Newborns with G-6-PD may have prolonged and more pronounced neonatal jaundice than other newborns. Older individuals are subject to hemolytic anemia that can be induced by some foods, drugs, and infections.

This test reuired rior to starting IV High Dose Vitamin C Therapy at Hydrations Wellness.

Test results include: G-6-PD Quantitative

Gamma Glutamyl Transferase (GGT) – Elevated GGT is found in all forms of liver disease. Measurement of GGT is used in the diagnosis and treatment of alcoholic cirrhosis, as well as primary and secondary liver tumors. It is more sensitive than alkaline phosphatase, the transaminases, and leucine aminopeptidase in detecting obstructive jaundice, cholangitis, and cholecystitis. Normal levels of GGT are seen in skeletal diseases; thus, GGT in serum can be used to ascertain whether a disease, suggested by elevated alkaline phosphatase, is skeletal or hepatobiliary.

Test results include: GGT

Homocysteine – An elevated concentration of homocysteine is an independent risk factor for cardiovascular disease. When used in conjunction with methylmalonic acid (MMA), these tests are useful to diagnose and monitor vitamin B12 (cobalamin) and folic acid deficiency and are often useful in evaluating macrocytosis (an elevated MCV, an erythrocytic index).

Test results include: Homocysteine

Iron, Total and Total Iron Binding Capacity – Serum iron quantification is useful in confirming the diagnosis of iron-deficiency anemia or hemochromatosis. The measurement of total iron binding in the same specimen may facilitate the clinician’s ability to distinguish between low serum iron levels caused by iron deficiency from those related to inflammatory neoplastic disorders. The assay for iron measures the amount of iron which is bound to transferrin. The total iron binding capacity (TIBC) measures the amount of iron that would appear in blood if all the transferrin were saturated with iron. It is an indirect measurement of transferrin concentrations but expressed as an iron measurement. To obtain the percent saturation, the serum iron is divided by the TIBC which gives the actual amount of saturated transferrin. The percent saturation is low in iron deficiency and high in iron storage diseases. (Test should be done in the morning after fasting)

Test results include: Iron, Total – Total Iron Binding Capacity

Lipid Panel, Standard – Comprehensive lipid assessment aids in the evaluation of cardiovascular risk and the likelihood of suffering an ischemic event. It is also useful for the prevention and management of atherosclerotic disease, as well as the diagnosis of metabolic syndrome. Cardiovascular disease (CVD) is the leading cause of death in the United States. The risk of developing CVD and having an ischemic event is significantly increased in individuals with high LDL-cholesterol (LDL-C) and TG levels [2,3]. The American Heart Association (AHA) recommends that Americans aged 20 and above have their lipid levels tested every 4 to 6 years.

Test results include: cholesterol/HDL-C ratio (calculated), HDL-C, LDL-C (calculated), non-HDL-C (calculated), total cholesterol, and Triglycerides.

Magnesium – Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of magnesium). Magnesium is decreased in chronic nephritis, acute pancreatitis, and alcoholic cirrhosis. It is increased in acute or chronic renal failure and Addison’s Disease.

Test results include: Magnesium

Progesterone, Immunoassay – Levels increase sharply during the luteal phase of the menstrual cycle. The level increases from 9 to 32 weeks of pregnancy.

Test results include: Progesterone

PSA, Total – Elevated serum PSA concentrations have been reported in men with prostate cancer, benign prostatic hypertrophy, and inflammatory conditions of the prostate.

Test results include: PSA, total

Prothrombin Time with INR – Screening test for abnormalities of coagulation factors that are involved in the extrinsic pathway. Also used to monitor effects of Warfarin therapy and to study patients with hereditary and acquired clotting disorders.

Test results include: PT/INR

Testosterone, Free – Helpful in assessing testicular function in males. This test is for Males only. Females wanting testosterone checked should use test #14966.

Test results include: Testosterone, Free, Total, Bioavailable

Thyroid Panel – This test delivers an enhanced thyroid profile because it screens for the level of free T4 and T3 hormones in the bloodstream. This is an important distinction, since the level of free T4 hormone illustrates how much is immediately available for uptake and use by cells, and measure of free T3 hormone in the body is considered a more accurate view of hormonal balance than a total T3 reading.

Test results include: T3 Free, T3 Uptake, T4 Free, T4 Total and TSH

Transferrin – Transferrin is a direct measure of the iron binding capacity. Transferrin is thus useful in assessing iron balance. Iron deficiency and overload are often evaluated with complementary laboratory tests. (Fasting required)

Test results include: Transferrin

Uric Acid – Serum uric acid measurements are useful in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and in patients receiving cytotoxic drugs.

Test results include: Uric Acid

Vitamin B₁₂ – B12 is decreased in pernicious anemia, total or partial gastrectomy, malabsorption and certain congenital and biochemical disorders.

Test results include: Vitamin B-12

Vitamin D, 25-Hydroxy, Total, Immunoassay – Measurement of serum 25-OH vitamin D concentrations provide a good index of circulating vitamin D activity in patients not suffering from renal disease. Lower than normal 25-OH vitamin D levels can result from a dietary deficiency, poor absorption of the vitamin or impaired metabolism of the sterol in the liver. A 25-OH vitamin D deficiency can lead to bone diseases such as rickets and osteomalacia. Above normal levels can lead to hypercalcemia

>8 Hour Fasting Preferred But Not Required

Test results include: Vitamin D, 25-Hydroxy, Total, Immunoassay

Vitamin A (Retinol) – Vitamin A is critical for vision, growth, and many cell functions. High concentrations of Vitamin A are seen with renal failure, but this is not associated with toxicity and excessive ingestion. High concentrations are associated with bone fractures. Low concentrations of Vitamin A are consistent with fat malabsorption and are rarely due to inadequate diet. (Fasting required)

This test requires 12 hour of fasting prior to lab draw

Test Results include: Vitamin A (Retinol)

Vitamin E (Tocophereol) – Deficiency of vitamin E may cause extensive neuropathy in young children and, in addition, is suspect as a possible cause of motor and sensory neuropathy in older children and in adults. One likely cause of vitamin E deficiency is intestinal malabsorption, resulting from bowel disease, pancreatic disease, or chronic cholestasis. Other causes of malabsorption of vitamin E include celiac disease, cystic fibrosis, and intestinal lymphangiectasia. (Fasting required)

This test requires 12 hour of fasting prior to lab draw

Test Results include: Vitamin E (Tocophereol)

CMP – The Comprehensive Metabolic Panel test provides an important summary of heart health, as well as liver and kidney function.

Test results include: Albumin, Albumin/Globulin Ratio (calculated), Alkaline Phosphatase, ALT, AST, BUN/Creatinine Ratio (calculated), Calcium, Carbon Dioxide, Chloride, Creatinine with GFR Estimated, Globulin (calculated), Glucose, Potassium, Sodium, Total Bilirubin, Total Protein, Urea Nitrogen

Complete Blood Count w/Differential – CBC (includes Differential and Platelets) – A complete blood count is used as a screening test for various disease states to include: anemia, leukemia and inflammatory processes.

Test results include: WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, RDW, Platelet Count, MPV with Differential

Lipid Panel, Standard – Comprehensive lipid assessment aids in the evaluation of cardiovascular risk and the likelihood of suffering an ischemic event. It is also useful for the prevention and management of atherosclerotic disease, as well as the diagnosis of metabolic syndrome. Cardiovascular disease (CVD) is the leading cause of death in the United States. The risk of developing CVD and having an ischemic event is significantly increased in individuals with high LDL-cholesterol (LDL-C) and TG levels [2,3]. The American Heart Association (AHA) recommends that Americans aged 20 and above have their lipid levels tested every 4 to 6 years.

Test results include: cholesterol/HDL-C ratio (calculated), HDL-C, LDL-C (calculated), non-HDL-C (calculated), total cholesterol, and Triglycerides.

Diabetic Screen – Hemoglobin A1c – To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.

Test results include: Hemoglobin A1c

CMP – The Complete Metabolic Panel test provides an important summary of heart health, as well as liver and kidney function.

Test results include: Albumin, Albumin/Globulin Ratio (calculated), Alkaline Phosphatase, ALT, AST, BUN/Creatinine Ratio (calculated), Calcium, Carbon Dioxide, Chloride, Creatinine with GFR Estimated, Globulin (calculated), Glucose, Potassium, Sodium, Total Bilirubin, Total Protein, Urea Nitrogen

Complete Blood Count w/Differential – CBC (includes Differential and Platelets) – A complete blood count is used as a screening test for various disease states to include: anemia, leukemia and inflammatory processes.

Test results include: WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, RDW, Platelet Count, MPV with Differential

Lipid Panel, Standard – Comprehensive lipid assessment aids in the evaluation of cardiovascular risk and the likelihood of suffering an ischemic event. It is also useful for the prevention and management of atherosclerotic disease, as well as the diagnosis of metabolic syndrome. Cardiovascular disease (CVD) is the leading cause of death in the United States. The risk of developing CVD and having an ischemic event is significantly increased in individuals with high LDL-cholesterol (LDL-C) and TG levels [2,3]. The American Heart Association (AHA) recommends that Americans aged 20 and above have their lipid levels tested every 4 to 6 years.

Test results include: cholesterol/HDL-C ratio (calculated), HDL-C, LDL-C (calculated), non-HDL-C (calculated), total cholesterol, and Triglycerides.

Iron, Total and Total Iron Binding Capacity – Serum iron quantification is useful in confirming the diagnosis of iron-deficiency anemia or hemochromatosis. The measurement of total iron binding in the same specimen may facilitate the clinician’s ability to distinguish between low serum iron levels caused by iron deficiency from those related to inflammatory neoplastic disorders. The assay for iron measures the amount of iron which is bound to transferrin. The total iron binding capacity (TIBC) measures the amount of iron that would appear in blood if all the transferrin were saturated with iron. It is an indirect measurement of transferrin concentrations but expressed as an iron measurement. To obtain the percent saturation, the serum iron is divided by the TIBC which gives the actual amount of saturated transferrin. The percent saturation is low in iron deficiency and high in iron storage diseases.

Test results include: Iron, Total – Total Iron Binding Capacity

TSH – For differential diagnosis of primary, secondary, and tertiary hypothyroidism. Also useful in screening for hyperthyroidism. This assay allows adjustment of exogenous thyroxine dosage in hypothyroid patients and in patients on suppressive thyroxine therapy for thyroid neoplasia.

Test results include: TSH

Gamma Glutamyl Transferase (GGT) – Elevated GGT is found in all forms of liver disease. Measurement of GGT is used in the diagnosis and treatment of alcoholic cirrhosis, as well as primary and secondary liver tumors. It is more sensitive than alkaline phosphatase, the transaminases, and leucine aminopeptidase in detecting obstructive jaundice, cholangitis, and cholecystitis. Normal levels of GGT are seen in skeletal diseases; thus, GGT in serum can be used to ascertain whether a disease, suggested by elevated alkaline phosphatase, is skeletal or hepatobiliary.

Test results include: GGT

Diabetic Screen – Hemoglobin A1c – To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.

Test results include: Hemoglobin A1c

Magnesium – Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of magnesium). Magnesium is decreased in chronic nephritis, acute pancreatitis, and alcoholic cirrhosis. It is increased in acute or chronic renal failure and Addison’s Disease.

Test results include: Magnesium

Uric Acid – Serum uric acid measurements are useful in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and in patients receiving cytotoxic drugs.

Test results include: Uric Acid

Progesterone, Immunoassay – Levels increase sharply during the luteal phase of the menstrual cycle. The level increases from 9 to 32 weeks of pregnancy.

Test results include: Progesterone

FSH and LH – FSH and LH are secreted by the anterior pituitary in response to gonadotropin-releasing hormone (GNRH) secreted by the hypothalamus. In both males and females, FSH and LH secretion is regulated by a balance of positive and negative feedback mechanisms involving the hypothalamic-pituitary axis, the reproductive organs, and the pituitary and sex steroid hormones. FSH and LH play a critical role in maintaining the normal function of the male and female reproductive systems. Abnormal FSH levels with corresponding increased or decreased levels of LH, estrogens, progesterone, and testosterone are associated with a number of pathological conditions. Increased FSH levels are associated with menopause and primary ovarian hypofunction in females and primary hypogonadism in males. Decreased levels of FSH are associated with primary ovarian hyper-function in females and primary hypergonadism in males. Normal or decreased levels of FSH are associated with polycystic ovary disease in females. In males, LH is also called interstitial cell-stimulating hormone (ICSH). Abnormal LH levels with corresponding increased or decreased levels of FSH, estrogens, progesterone, and testosterone are associated with a number of pathological conditions. Increased LH levels are associated with menopause, primary ovarian hypofunction, and polycystic ovary disease in females and primary hypo-gonadism in males. Decreased LH levels are associated with primary ovarian hyperfunction in females and primary hyper-gonadism in males.

Test results include: FSH, LH

DHEA-S is the sulfated form of DHEA and is the major androgen produced by the adrenal glands. This test is used in the differential diagnosis of hirsute or virilized female patients and for the diagnosis of isolated premature adrenarche and adrenal tumors. About 10% of hirsute women with Polycystic Ovarian Syndrome (PCOS) have elevated DHEA-S but normal levels of other androgens.

Test results include: DHEA-S Immunoassay

Estrogen, Total, Serum – Estrogens are secreted by the gonads, adrenal glands, and placenta. Total estrogens provide an overall picture of estrogen status for men and women

Test results include: Estrogen Total

Testosterone, Total – Helpful in assessing testicular function in males and managing hirsutism, virilization in females.

Test results include: Testosterone, Total

Testosterone, Free, Total, Bioavailable – Helpful in assessing testicular function in males.

Test results include: Testosterone, Free, Tota, Bioavailable, Albumin

PSA, Total – Elevated serum PSA concentrations have been reported in men with prostate cancer, benign prostatic hypertrophy, and inflammatory conditions of the prostate.

Test results include: PSA, total

Alpha-Fetoprotein, Tumor Marker – Elevation of serum AFP above values found in healthy individuals occurs in several malignant diseases, most notably nonseminomatous testicular cancer and primary hepatocellular carcinoma. AFP is not recommended as a screening procedure to detect cancer in the general population.

Test results include: Alpha-Fetoprotein

Thyroid Panel – This test delivers an enhanced thyroid profile because it screens for the level of free T4 and T3 hormones in the bloodstream. This is an important distinction, since the level of free T4 hormone illustrates how much is immediately available for uptake and use by cells, and measure of free T3 hormone in the body is considered a more accurate view of hormonal balance than a total T3 reading.

Test results include: T3 Free, T3 Uptake, T4 Free, T4 Total and TSH

Thyroid Antibodies The Thyroglobulin antibodies and thyroid peroxidase antibodies test is useful in the diagnosis and management of a variety of thyroid disorders including autoimmune thyroiditis, Hashimoto’s Disease, Graves Disease and certain types of goiter.

Test results include: Thyroid Peroxidase Ab, Thyroglobulin Ab

CA 125 – The CA 125 level can provide prognostic information in the follow-up management of patients with ovarian carcinoma. The assay should be used as an adjunctive test in the management of ovarian cancer patients. CA 125 is not recommended as a cancer screening procedure to detect cancer in the general population.

Test results include: CA 125

CA 15-3 – CA 15-3 may be useful for monitoring patients with metastatic breast cancer and certain ovarian cancers. The CA 15-3 values from sequential samples have a high correlation with the clinical course in most patients with metastatic breast cancer.

Test results include: CA 15-3

CA 19-9 – A large percentage of patients with gastrointestinal tumors (such as pancreatic, liver, gastric, colorectal tumors) and some other malignancies have been shown to have elevated serum CA 19-9 levels. Serum CA 19-9 levels may be useful for monitoring disease activity or predicting relapse following treatment. CA 19-9 should not be used as a screening test.

Test results include: CA 19-9

CA 27.29 – CA 27.29 may be useful for monitoring patients for metastatic breast cancer.

Test results include: CA 27.29

CEA – Increased serum CEA levels have been detected in persons with primary colorectal cancer and in patients with other malignancies involving the gastrointestinal tract, breast, lung, ovarian, prostatic, liver and pancreatic cancers. Elevated serum CEA levels have also been detected in patients with nonmalignant disease, especially patients who are older or who are smokers. CEA levels are not useful in screening the general population for undetected cancers. However, CEA levels provide important information about patient prognosis, recurrence of tumors after surgical removal, and effectiveness of therapy.

Test results include: CEA

High Sensitivity C-Reactive Protein (hs-CRP) – Useful in predicting risk for cardiovascular disease.

Test results include: CRP

Sed Rate by Modified Westergren (ESR) – Useful in differentiating inflammatory and neoplastic diseases and as an index of disease severity. CRP is also useful in monitoring inflammatory disease states.

Test results include: Sed Rate by Modified Westergren

Homocysteine – An elevated concentration of homocysteine is an independent risk factor for cardiovascular disease. When used in conjunction with methylmalonic acid (MMA), these tests are useful to diagnose and monitor vitamin B12 (cobalamin) and folic acid deficiency and are often useful in evaluating macrocytosis (an elevated MCV, an erythrocytic index).

Test results include: Homocysteine

Complete Blood Count w/Differential – CBC (includes Differential and Platelets) – A complete blood count is used as a screening test for various disease states to include: anemia, leukemia and inflammatory processes.

Test results include: WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, RDW, Platelet Count, MPV with Differential

Iron, Total and Total Iron Binding Capacity – Serum iron quantification is useful in confirming the diagnosis of iron-deficiency anemia or hemochromatosis. The measurement of total iron binding in the same specimen may facilitate the clinician’s ability to distinguish between low serum iron levels caused by iron deficiency from those related to inflammatory neoplastic disorders. The assay for iron measures the amount of iron which is bound to transferrin. The total iron binding capacity (TIBC) measures the amount of iron that would appear in blood if all the transferrin were saturated with iron. It is an indirect measurement of transferrin concentrations but expressed as an iron measurement. To obtain the percent saturation, the serum iron is divided by the TIBC which gives the actual amount of saturated transferrin. The percent saturation is low in iron deficiency and high in iron storage diseases.

Test results include: Iron, Total – Total Iron Binding Capacity

Homocysteine – An elevated concentration of homocysteine is an independent risk factor for cardiovascular disease. When used in conjunction with methylmalonic acid (MMA), these tests are useful to diagnose and monitor vitamin B12 (cobalamin) and folic acid deficiency and are often useful in evaluating macrocytosis (an elevated MCV, an erythrocytic index).

Test results include: Homocysteine

Ferritin – Useful in the diagnosis of hypochromic, microcytic anemias. Decreased in iron deficiency anemia and increased in iron overload.

Test results include: Ferritin

Epstein-Barr Virus Antibody Panel – Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. VCA-IgM is typically detectable at clinical presentation, then declines to undetectable levels within a month in young children and within 3 months in other individuals. VCA-IgG is typically detectable at clinical presentation, and persists for life. EBNA IgG typically appears during convalescence (3-4 months after clinical presentation) and remains detectable for life.

Test results include: Epstein-Barr Virus VCA Antibody (IgM), Epstein-Barr Virus VCA Antibody (IgG), Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG)

Epstein-Barr Virus Early Antigen D Antibody (IgG) – Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. IgG recognizing Early Antigen D typically appears within a month after clinical presentation and is transient, lasting only 3-4 months. Persistently elevated levels suggest reactivation or persistence of EBV infection.

Test results include: Epstein-Barr Virus Early Antigen D Antibody (IgG)